Introduction
Between 2009 and 2011, we reported the lactose and galactose content of a range of 15 cheese types, some of which are suitable in a low galactose diet for patients with galactosaemia [1, 2] . We have extended the analysis to milk fats (butter, ghee, butter oils). These products are predominantly milk fat based and are likely to be low in lactose and galactose. Milk fats have many functional properties and are widely used in food manufacture and catering, and if suitable to incorporate into the diets of patients with galactosaemia they would increase the palatability and ease of dietary management. We report the lactose and galactose analysis of butter, ghee, and butter oil.
Methods
Five samples of butter oil and 3 samples of ghee were supplied by Meadows Foods and KTC respectively from 2013 to 2014. Two samples each of butter and ghee were purchased from retail outlets between 2011 and 2014. They were prepared and analysed by Leatherhead Food Research. High-Performance Anion Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) technology was used to perform lactose and galactose analysis. The HPAEC-PAD had a limit of detection of lactose and galactose of b 1.0 mg/100 g for the 2011 analysis. This was further refined to b0.5 mg/100 g from the 2013 analysis onwards. (Table 1) 3.1. Butter oil (n = 5 samples)
Results
The lactose content varied from 0.47 to 3.08 mg/100 g and galactose was b 0.05 to 2.28 mg/100 g.
Ghee (n = 5 samples)
The lactose content varied between b 0.05 and 2.9 mg/100 g and galactose was b0.05 mg to b1.0 mg/100 g (the galactose content was always below the lower level of detection in three separate analyses).
Butter (n = 2 samples)
The lactose content varied between 685 and 688 mg/100 g and galactose was 1.3 mg to 1.6 mg/100 g.
Discussion
The UK Galactosaemia Support Group (GSG) Medical Advisory Panel regard that any 'cheese' with a lactose and galactose content of 
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Ghee is clarified butter and contains approximately 99.3% milk fat and it was also consistently low in lactose and galactose. It originates from India and Pakistan and is commonly used in Kurdish, Afghani, Pakistani, Indian, Bangladeshi and Sri Lankan cooking. It is made by heating butter and removing the non-fat milk solids from the oil. Restaurants serving Asian food commonly use ghee to serve with roti or rice or incorporate it into curries or daal (lentils), or for other cooking purposes. It is used for deep frying as it has a high smoke point.
Butter is an emulsion of butterfat, water and air, made by churning fresh or fermented cream or milk. It contains approximately 80% fat, with the remainder being constituted by moisture, milk protein and lactose from the milk or cream. 10 g of butter (the amount added to 1 slice of bread) would provide almost 70 mg of lactose, delineating its unsuitability in a low galactose diet. If a patient consumed 4 slices of bread per day, the intake of lactose would provide 280 mg/day from this source. We have little evidence to suggest that this daily amount would be safe for children and so butter is best avoided. However, interestingly, butter appeared to be low in galactose. The reason for this is not clear and further analysis may be warranted to verify this analysis.
This analysis of ghee, butter oil and butter was specifically to determine the lactose and galactose content only and not milk protein, although the milk protein content of butter oil and ghee should be lower than butter. Although there was some small variability in lactose/galactose analysis, particularly for butter oil, the amount (maximum 3 mg/100 g for 5 samples), is clinically not significant. It is known that the intake of galactose from a low galactose diet allowing fruit and vegetables will provide 17 to 54 mg/day [4, 5] , and these foods are permitted in the diet by many countries and are considered safe. Therefore, any trace amount of lactose and galactose provided from butter oil is inconsequential.
In conclusion, this analysis has enabled butter oil and ghee to be permitted into a low galactose diet. Both products will help expand the food choice and cuisine available to patients with galactosaemia. It is essential that any new or existing ingredients that may contain lactose/ galactose are systematically analysed before inclusion in a low galactose diet.
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